The American Recovery and Reinvestment Act of 2009 provided $1.1 billion for comparative effectiveness research (CER). The Patient Protection and Affordable Care Act established the Patient-Centered ...
The goal of comparative effectiveness research is to inform clinical decisions between alternate treatment strategies using data that reflect real patient populations and real-world clinical scenarios ...
Comparative effectiveness research has been the target of recurrent criticism in some political circles, with opponents claiming it’s the “gateway to rationing” or it encourages “cookbook medicine.” ...
Rigorous scientific standards are needed to address the challenge of providing information on the real-world effects of treatments and procedures. With enactment of healthcare reform legislation now a ...
In the article that accompanies this editorial, Lu et al 5 conducted a systematic review on the use of instrumental variable (IV) methods in oncology comparative effectiveness research. The main ...
PCORI also is offering up to $200 million through the Phased Large Awards for Comparative Clinical Effectiveness Research (PLACER) PFA, for ambitious, large-scale two-phased trials addressing critical ...
The Purdue University Board of Trustees has approved the naming of the Evan and Sue Ann Werling Comparative Oncology Research Center in recognition of the donors’ $10 million gift. The center, part of ...
The importance of science advice—broadly defined here as practices for mobilizing scientific knowledge in support of public decision-making—is now widely accepted (OECD, 2015). Over the last decade, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results